What is the optimal schedule for multiparametric MRS? A magnetic resonance fingerprinting perspective
暂无分享,去创建一个
[1] Yonina C. Eldar,et al. Low‐rank magnetic resonance fingerprinting , 2017, Medical physics.
[2] T. Ernst,et al. Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.
[3] Andrew R. Mayer,et al. Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study. , 2009 .
[4] C. Elster,et al. Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.
[5] O. Volovyk,et al. Application of phase rotation to STRESS localization scheme at 3 T , 2018, Magnetic resonance in medicine.
[6] S. Provencher. Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.
[7] Jun Shen,et al. Fast computation of full density matrix of multispin systems for spatially localized in vivo magnetic resonance spectroscopy , 2017, Medical physics.
[8] R. Gillies,et al. In vivo magnetic resonance spectroscopy in cancer. , 2005, Annual review of biomedical engineering.
[9] Jürgen Gieseke,et al. 1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation , 2004, Journal of magnetic resonance imaging : JMRI.
[10] A. Padhani,et al. Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer? , 2015, Diagnostic and interventional radiology.
[11] Ouri Cohen,et al. Algorithm comparison for schedule optimization in MR fingerprinting. , 2017, Magnetic resonance imaging.
[12] Assaf Tal,et al. The application of magnetic resonance fingerprinting to single voxel proton spectroscopy , 2018, NMR in biomedicine.
[13] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[14] J. Moffett,et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.
[15] H. Lanfermann,et al. Regional Metabolite Concentrations in Aging Human Brain: Comparison of Short-TE Whole Brain MR Spectroscopic Imaging and Single Voxel Spectroscopy at 3T , 2019, Clinical Neuroradiology.
[16] O. Henriksen,et al. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. , 1995, Magnetic resonance imaging.
[17] J. Babb,et al. Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. , 2010, Radiology.
[18] Akira Matsumura,et al. Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. , 2002, Magnetic resonance imaging.
[19] A Horsman,et al. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours , 1995, NMR in biomedicine.
[20] Assaf Tal,et al. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS , 2013, Neurology.
[21] T. Sobów,et al. Magnetic Resonance Spectroscopy in the Diagnosis of Dementia with Lewy Bodies , 2014, BioMed research international.
[22] M. Oudkerk,et al. 1H chemical shift imaging characterization of human brain tumor and edema , 2002, European Radiology.
[23] O. Gonen,et al. Spectroscopic localization by simultaneous acquisition of the double‐spin and stimulated echoes , 2015, Magnetic resonance in medicine.
[24] D. Reich,et al. Reproducibility and optimization of in vivo human diffusion‐weighted MRS of the corpus callosum at 3T and 7T , 2015, NMR in biomedicine.
[25] Hoby P Hetherington,et al. MRSI of the medial temporal lobe at 7 T in explosive blast mild traumatic brain injury , 2014, Magnetic resonance in medicine.
[26] Phil Lee,et al. Doubly selective multiple quantum chemical shift imaging and T1 relaxation time measurement of glutathione (GSH) in the human brain in vivo , 2013, NMR in biomedicine.
[27] Michael Garwood,et al. Imaging in breast cancer: Magnetic resonance spectroscopy , 2005, Breast Cancer Research.
[28] Andrea Bergmann,et al. Statistical Parametric Mapping The Analysis Of Functional Brain Images , 2016 .
[29] L DelaBarre,et al. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.
[30] Dennis W J Klomp,et al. Short echo time 1H‐MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses , 2008, Magnetic resonance in medicine.
[31] Ying Lu,et al. Comparison of T1 and T2 metabolite relaxation times in glioma and normal brain at 3T , 2008, Journal of magnetic resonance imaging : JMRI.
[32] Assaf Tal,et al. Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury. , 2013, Journal of neurotrauma.
[33] Brian J Soher,et al. A review of 1H MR spectroscopy findings in Alzheimer's disease. , 2005, Neuroimaging clinics of North America.
[34] Ponnada A Narayana,et al. Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[35] J. Duerk,et al. Magnetic Resonance Fingerprinting , 2013, Nature.
[36] J. Frahm,et al. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.
[37] Rolf Gruetter,et al. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.
[38] Ze Wang,et al. Magnetic Resonance Fingerprinting Using a Fast Dictionary Searching Algorithm: MRF-ZOOM , 2019, IEEE Transactions on Biomedical Engineering.
[39] Abhishek Banerjee,et al. T2 measurement of J‐coupled metabolites in the human brain at 3T , 2012, NMR in biomedicine.
[40] Karl Landheer,et al. A rapid inversion technique for the measurement of longitudinal relaxation times of brain metabolites: application to lactate in high‐grade gliomas at 3 T , 2016, NMR in biomedicine.
[41] Chris Boesch,et al. Two-dimensional linear-combination model fitting of magnetic resonance spectra to define the macromolecule baseline using FiTAID, a Fitting Tool for Arrays of Interrelated Datasets , 2011, Magnetic Resonance Materials in Physics, Biology and Medicine.
[42] Michael Erb,et al. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla , 2003, Magnetic resonance in medicine.
[43] Assaf Tal,et al. Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis , 2020, Magnetic resonance in medicine.
[44] G. E. Alexander,et al. Brain metabolite concentration and dementia severity in Alzheimer’s disease , 2001, Neurology.
[45] Itamar Ronen,et al. Differences in apparent diffusion coefficients of brain metabolites between grey and white matter in the human brain measured at 7 T , 2012, Magnetic resonance in medicine.
[46] R. Kauppinen,et al. Quantitative Metabolite Patterns of Human Brain Tumors: Detection by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of computer assisted tomography.
[47] Lawrence L. Wald,et al. Simultaneous multislice magnetic resonance fingerprinting with low-rank and subspace modeling , 2017, 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[48] Justin P. Haldar,et al. Optimal experiment design for magnetic resonance fingerprinting , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[49] F Barkhof,et al. Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.
[50] Robert Bartha,et al. Effect of signal‐to‐noise ratio and spectral linewidth on metabolite quantification at 4 T , 2007, NMR in biomedicine.
[51] S. Holland,et al. NMR relaxation times in the human brain at 3.0 tesla , 1999, Journal of magnetic resonance imaging : JMRI.
[52] Daniel Pelletier,et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.
[53] Shi-Jiang Li,et al. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.
[54] Yvonne W. Lui,et al. Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study , 2012, Journal of Neurology.
[55] C. Laule,et al. Proton MRS of large multiple sclerosis lesions reveals subtle changes in metabolite T1 and area , 2010, NMR in biomedicine.
[56] Oded Gonen,et al. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T , 2008, Magnetic resonance in medicine.
[57] E Moser,et al. Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.
[58] Gadi Goelman,et al. Optimizing the efficiency of high‐field multivoxel spectroscopic imaging by multiplexing in space and time , 2006, Magnetic resonance in medicine.
[59] Bo Zhu,et al. MR fingerprinting Deep RecOnstruction NEtwork (DRONE) , 2017, Magnetic resonance in medicine.